Detailed analysis of *C. aurimucosum*, tracing its classification through advanced genomic identification to its role as an opportunistic pathogen and antibiotic challenges.
Understand the critical criteria distinguishing Unfavorable Intermediate-Risk prostate cancer and the resulting shift in definitive treatment strategy.